StockStory.org on MSN11h
Beyond Meat (NASDAQ:BYND) Exceeds Q4 ExpectationsPlant-based protein company Beyond Meat (NASDAQ:BYND) announced in Q4 CY2024, with sales up 4% year on year to $76.66 million ...
Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) in Q4 CY2024, with sales up 35% year on year to $282.6 million ...
The tech-heavy Nasdaq led Wall Street's main indexes higher on Wednesday as chip stocks rebounded ahead of Nvidia's results ...
StockStory.org on MSN11h
Sarepta Therapeutics’s (NASDAQ:SRPT) Q4: Beats On RevenueBiotech company Sarepta Therapeutics (NASDAQ:SRPT) announced in Q4 CY2024, with sales up 65.9% year on year to $658.4 million ...
Super Micro also filed results for the first two quarters of the fiscal 2025 year and said it has "regained compliance" with ...
1d
Investing News Network on MSNStem Cell Stocks: 10 Biggest NASDAQ Companies in 2025Stem cell research and regenerative medicine are growing markets in the life science sector, and the top stem cell companies ...
StockStory.org on MSN11h
Nvidia’s (NASDAQ:NVDA) Q4 Sales Top Estimates, Provides Encouraging Quarterly Revenue GuidanceLeading designer of graphics chips Nvidia (NASDAQ:NVDA) reported in Q4 CY2024, with sales up 77.9% year on year to $39.33 ...
Hosted on MSN10h
SunOpta (NASDAQ:STKL) Posts Q4 Sales In Line With EstimatesPlant-based food and beverage company SunOpta (NASDAQ:STKL) in Q4 CY2024, with sales up 6.8% year on year to $193.9 million.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results